|Day's Range||798.25 - 798.25|
|52 Week Range||798.25 - 798.25|
|PE Ratio (TTM)||277.27|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Bristol-Myers reported a net profit of ~$1.57 billion in 1Q17—compared to $1.19 billion in 1Q16. Analysts expect a net profit of $1.18 billion during 2Q16.
Bristol-Myers Squibb (BMY) reported 12% growth in its top line to ~$4.93 billion during 1Q17 due to 13% operational growth in its revenues
As of June 20, 2017, Bristol-Myers Squibb was trading at a forward PE multiple of ~18.0x—compared to the industry average of 16.0x.